Off-pump versus on-pump coronary artery surgery.
暂无分享,去创建一个
[1] Keyvan Karkouti,et al. A propensity score case‐control comparison of aprotinin and tranexamic acid in high‐transfusion‐risk cardiac surgery , 2006, Transfusion.
[2] I. C. Tudor,et al. The risk associated with aprotinin in cardiac surgery. , 2006, The New England journal of medicine.
[3] Z. Straka,et al. Fibrinolytic inhibitors in off-pump coronary surgery: a prospective, randomized, double-blind TAP study (tranexamic acid, aprotinin, placebo). , 2005, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.
[4] J. Vaage,et al. Hemostasis in off-pump compared to on-pump coronary artery bypass grafting: a prospective, randomized study. , 2005, The Annals of thoracic surgery.
[5] C D Deakin,et al. Reducing allogeneic transfusion in cardiac surgery: a randomized double-blind placebo-controlled trial of antifibrinolytic therapies used in addition to intra-operative cell salvage. , 2005, British journal of anaesthesia.
[6] A. Bengtsson,et al. A closed perfusion system with heparin coating and centrifugal pump improves cardiopulmonary bypass biocompatibility in elderly patients. , 2004, The Annals of thoracic surgery.
[7] T. Treasure,et al. Effect of aprotinin on clinical outcomes in coronary artery bypass graft surgery: a systematic review and meta-analysis of randomized clinical trials. , 2004, The Journal of thoracic and cardiovascular surgery.
[8] J. Andreasen,et al. Prophylactic tranexamic acid in elective, primary coronary artery bypass surgery using cardiopulmonary bypass. , 2004, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.
[9] O. Alfieri,et al. Effects of tranexamic acid on postoperative bleeding and related hematochemical variables in coronary surgery: Comparison between on-pump and off-pump techniques. , 2004, The Journal of thoracic and cardiovascular surgery.
[10] H. Wendel,et al. Hemocompatibility of PMEA Coated Oxygenators Used for Extracorporeal Circulation Procedures , 2004, ASAIO journal.
[11] T. Carrel,et al. Off-pump coronary artery bypass operation does not increase procoagulant and fibrinolytic activity: preliminary results. , 2004, The Annals of thoracic surgery.
[12] L. Menicanti,et al. Reduced Systemic Heparin Dose with Phosphorylcholine Coated Closed Circuit in Coronary Operations , 2004, The International journal of artificial organs.
[13] K. Eishi,et al. Inflammatory response after coronary revascularization: off-pump versus on-pump (heparin-coated circuits and poly2methoxyethylacrylate-coated circuits). , 2004, Annals of thoracic and cardiovascular surgery : official journal of the Association of Thoracic and Cardiovascular Surgeons of Asia.
[14] P. Widimsky,et al. Off-pump versus on-pump coronary surgery: final results from a prospective randomized study PRAGUE-4. , 2004, The Annals of thoracic surgery.
[15] D. W. Fried,et al. Off-pump coronary artery bypass surgery may produce a hypercoagulable patient. , 2005, The heart surgery forum.
[16] E. Tremoli,et al. Biological effects of off-pump vs. on-pump coronary artery surgery: focus on inflammation, hemostasis and oxidative stress. , 2003, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.
[17] Z. Straka,et al. Tranexamic acid reduces bleeding after off-pump coronary artery bypass grafting. , 2003, The Journal of cardiovascular surgery.
[18] Z. Straka,et al. Less invasive cardiac anesthesia: an ultra-fast-track procedure avoiding thoracic epidural analgesia. , 2003, The heart surgery forum.
[19] R. Hetzer,et al. Hemostatic Activation and Inflammatory Response during Cardiopulmonary Bypass: Impact of Heparin Management , 2002, Anesthesiology.
[20] T. Carrel,et al. Aprotinin reduces blood loss in off-pump coronary artery bypass (OPCAB) surgery. , 2002, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.
[21] O. Alfieri,et al. Activation of Coagulation and Fibrinolysis during Coronary Surgery: On-pump versus Off-pump Techniques , 2001, Anesthesiology.
[22] O. Alfieri,et al. Tranexamic acid in off-pump coronary surgery: a preliminary, randomized, double-blind, placebo-controlled study. , 2001, The Annals of thoracic surgery.
[23] C. Whitten,et al. Thromboelastography: past, present, and future. , 2000, Anesthesiology.
[24] D. Warner. Isoflurane neuroprotection: a passing fantasy, again? , 2000, Anesthesiology.
[25] M. Horáček,et al. A retrospective survey of fibrinolysis as an indicator of poor outcome after cardiopulmonary bypass and a possible early sign of systemic inflammation syndrome. , 2000, European journal of anaesthesiology.
[26] G. Dhonneur,et al. Effects of overnight work on doctors' daytime activity: , 2000 .
[27] M. Prins,et al. Pharmacological strategies to decrease excessive blood loss in cardiac surgery: a meta-analysis of clinically relevant endpoints , 1999, The Lancet.
[28] W. van Oeveren,et al. Procoagulant activity after off-pump coronary operation: is the current anticoagulation adequate? , 1999, The Annals of thoracic surgery.
[29] R. Colman,et al. Pericardial blood activates the extrinsic coagulation pathway during clinical cardiopulmonary bypass. , 1996, Circulation.
[30] L. Mannucci,et al. One Month Follow-up of Haemostatic Variables in Patients Undergoing Aortocoronary Bypass Surgery , 1995, Thrombosis and Haemostasis.